The legacy of Viagra and its influence on the healthcare landscape presents a thorny question for potential backers. Initially a blockbuster drug, generics have significantly diminished its market presence , creating obstacles for companies involved to the original patent holder and subsequent formulas. While particular firms might benefit from spe